高级检索
当前位置: 首页 > 详情页

Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Capital Med Univ, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China [2]Capital Med Univ, Prote Res Ctr, Beijing 100069, Peoples R China [3]Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing 100069, Peoples R China [4]Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China [5]Capital Med Univ, Capital Med Univ Cardiff Univ Joint Ctr Biomed Re, Beijing 100069, Peoples R China [6]Cardiff Univ, Sch Med, Dept Surg, Metastasis & Angiogenesis Res Grp, Cardiff CF14 4XN, S Glam, Wales
出处:
ISSN:

关键词: Breast cancer NHERF1 PDZ PDGFR PTEN EBP50

摘要:
Na+/H+ exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a number of cancer-related proteins. nherf1 Mutations (K172N and D301V) were recently identified in breast cancer cells. To investigate the functional properties of NHERF1, wild-type and cancer-derived nherf1 mutations were stably expressed in SKMES-1 cells respectively. NHERF1-wt overexpression suppressed the cellular malignant phenotypes, including proliferation, migration, and invasion. nherf1 Mutations (K172N and D301V) caused complete or partial loss of NHERF1 functions by affecting the PTEN/NHERF1/PDGFR beta complex formation, inactivating NHERF1 inhibition of PDGF-induced AKT and ERK activation, and attenuating the tumor-suppressor effects of NHERF1-wt. These results further demonstrated the functional consequences of breast cancer-derived nherf1 mutations (K172N and D301V), and suggested the causal role of NHERF1 in tumor development and progression. Structured summary of protein interactions: NHERF1 physically interacts with PDGFRbeta by pull down NHERF1 physically interacts with PTEN by pull down PDGFRbeta physically interacts with PTEN and NHERF1 by pull down (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 3 区 生物
小类 | 3 区 生化与分子生物学 3 区 生物物理 4 区 细胞生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 3 区 生物物理 4 区 生化与分子生物学 4 区 细胞生物学
JCR分区:
出版当年[2011]版:
Q2 CELL BIOLOGY Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 BIOPHYSICS
最新[2023]版:
Q2 BIOPHYSICS Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2011版] 出版当年五年平均[2007-2011] 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]Capital Med Univ, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China [5]Capital Med Univ, Capital Med Univ Cardiff Univ Joint Ctr Biomed Re, Beijing 100069, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China [5]Capital Med Univ, Capital Med Univ Cardiff Univ Joint Ctr Biomed Re, Beijing 100069, Peoples R China [*1]Capital Med Univ, Dept Biochem & Mol Biol, 10 Xitoutiao, Beijing 100069, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)